Scholarly Index
Liang Ouyang
Sichuan University; 10,153 total citations; 218 total publications; best world rank #162
Sichuan University
10,153Total citations
218Total publications
54H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Autophagy in Disease and Therapy | Lifetime | 300 | CN 40 | 97.89 |
| Protein Degradation and Inhibitors | Lifetime | 603 | CN 31 | 95.89 |
| Ubiquitin and proteasome pathways | 2021-2025 | 173 | CN 83 | 93.24 |
| Protein Degradation and Inhibitors | 2021-2025 | 254 | CN 33 | 94.69 |
| Cancer therapeutics and mechanisms | 2021-2025 | 162 | CN 16 | 90.64 |
| Autophagy in Disease and Therapy | 2021-2025 | 385 | CN 191 | 89.93 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 297 | CN 71 | 88.11 |
| Melanoma and MAPK Pathways | 2021-2025 | 260 | CN 18 | 87.72 |
| Cancer-related gene regulation | 2021-2025 | 753 | CN 512 | 79.92 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 516 | CN 155 | 75.32 |
| PARP inhibition in cancer therapy | 2021-2025 | 977 | CN 98 | 77.85 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 507 | CN 113 | 70.17 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 446 | CN 48 | 58.49 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 981 | CN 344 | 53.22 |
| Synthesis of Tetrazole Derivatives | 2021-2025 | 199 | CN 24 | 53.77 |